Understanding the Final Guidance on Postmarketing Safety Reporting for Combination Products – An Interactive Analysis with FDA and Industry
Regulatory Affairs Professionals Society HQ
5635 Fishers Ln
Rockville, Maryland, USA, 20852-1796
Advanced therapies/cell and gene therapyAPIsBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsCosmeticsDiagnostics/IVDsDigital health/SaMD/AIGenericsMedical DevicesNutritional/Natural HealthOTCOtherPharmaceuticals